Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000834237-22-002390
Filing Date
2022-01-27
Accepted
2022-01-27 13:59:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 nl0012169213_012722.txt SC 13G/A 11887
  Complete submission text file 0000834237-22-002390.txt   13666
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Subject) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54659 | Film No.: 22562350
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies